ReviewHealthcare (Basel, Switzerland)2026
Patient-Reported Outcome Measures for Quality of Life in Adolescent Idiopathic Scoliosis: Validity, Reliability, and Clinical Utility-A Narrative Review.
Review in Healthcare (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatient-reported outcome measures are important for capturing health-related quality of life and treatment-specific concerns in adolescent idiopathic scoliosis (AIS).
objectiveThis narrative review aimed to summarize the validity, reliability, responsiveness, minimal clinically important difference, floor and ceiling effects, cross-cultural adaptation, and clinical utility of commonly used quality of life and treatment-specific patient-reported outcome measures in AIS.
methodsA narrative literature review was conducted focusing on frequently used AIS-related instruments, including the SRS-22/SRS-22r, SRS-7, QLPSD, ISYQOL, SJ-27, BSSQ-Brace/BSSQ-Deformity and BrQ. Evidence regarding psychometric properties and clinical applicability was synthesized narratively.
resultsMost instruments demonstrated acceptable to high internal consistency and test-retest reliability. Reported Cronbach's alpha values generally ranged from 0.71 to 0.96 for SRS-22/SRS-22r, 0.87 to 0.94 for QLPSD, 0.75 to 0.88 for ISYQOL, 0.898 to 0.991 for SJ-27, 0.80 to 0.87 for BSSQ-Brace/BSSQ-Deformity, and 0.82 to 0.96 for BrQ. Treatment-specific tools such as BSSQ and BrQ provide additional information on brace-related quality of life, stress, and coping. However, evidence on responsiveness, minimal clinically important difference, and conservative treatment-specific interpretability remains limited for most instruments.
conclusionsNo single instrument appears sufficient to capture the multidimensional impact of AIS. General quality of life measures should be selected according to the clinical or research question, and treatment-specific tools should be added when brace-related burden or stress is relevant. Future studies should further define responsiveness, minimal clinically important change, and longitudinal utility in conservative AIS management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.